JPMorgan Raises Eli Lilly Price Target to $1,400 on Mounjaro’s Obesity and Pediatric Momentum
Health Canada has approved Mounjaro for children with type 2 diabetes.
/ 220 items
#andre↓
BofA Sees AI Winners and Losers: Buy Figma & Shopify, Downgrade Adobe
BofA sees Adobe hurt by AI, while Figma and Shopify could benefit as AI boosts creativity, collaboration, and online commerce.
Benchmark Upgrades AbCellera to Buy with $11 Target on Major Jazz Pharmaceuticals Partnership
AbCellera gets a boost after Jazz deal brings upfront cash and future growth potential through cancer antibody programs and milestones.
Samsung’s 19-Fold Profit Surge Fueled by AI Chips, But Shares Plunge on Boom Worries
Investors fear the AI rally may be peaking.
JPMorgan, Bank of America, and Peers Eye Fiserv Debit Network in Bid to Reshape Payments
Several top U.S. banks are discussing the purchase of Fiserv’s debit card processing network. They hope to escape strict fee rules and make more from every debit swipe.
Kyntra Bio Scores First Analyst Coverage: Oppenheimer Initiates Outperform with $35 Target
Kyntra Bio gains analyst support as its cancer drugs advance, with key Phase 2 data expected to drive future growth.